Suppr超能文献

脑深部刺激术治疗肌张力障碍的类型。

Arching deep brain stimulation in dystonia types.

机构信息

Department of Neurology and Movement Disorder Center, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.

出版信息

J Neural Transm (Vienna). 2021 Apr;128(4):539-547. doi: 10.1007/s00702-021-02304-4. Epub 2021 Mar 19.

Abstract

Although medical treatment including botulinum toxic injection is the first-line treatment for dystonia, response is insufficient in many patients. In these patients, deep brain stimulation (DBS) can provide significant clinical improvement. Mounting evidence indicates that DBS is an effective and safe treatment for dystonia, especially for idiopathic and inherited isolated generalized/segmental dystonia, including DYT-TOR1A. Other inherited dystonia and acquired dystonia also respond to DBS to varying degrees. For Meige syndrome (craniofacial dystonia), other focal dystonia, and some rare inherited dystonia, further evidences are still needed to evaluate the role of DBS. Because short disease duration at DBS surgery and absence of fixed musculoskeletal deformity are associated with better outcome, DBS should be considered as early as possible when indicated after careful evaluation including genetic work-up. This review will focus on the factors to be considered in DBS for patients with dystonia and the outcome of DBS in the different types of dystonia.

摘要

尽管包括肉毒毒素注射在内的医学治疗是肌张力障碍的一线治疗方法,但许多患者的反应并不充分。在这些患者中,深部脑刺激(DBS)可以提供显著的临床改善。越来越多的证据表明,DBS 是一种有效且安全的肌张力障碍治疗方法,特别是对特发性和遗传性孤立性全身性/节段性肌张力障碍,包括 DYT-TOR1A。其他遗传性肌张力障碍和获得性肌张力障碍也在不同程度上对 DBS 有反应。对于 Meige 综合征(颅面部肌张力障碍)、其他局灶性肌张力障碍和一些罕见的遗传性肌张力障碍,仍需要更多证据来评估 DBS 的作用。由于 DBS 手术时疾病持续时间短且无固定的肌肉骨骼畸形与更好的结果相关,因此在经过仔细评估(包括基因检测)后,如果有指征,应尽早考虑 DBS。本综述将重点介绍 DBS 治疗肌张力障碍患者时需要考虑的因素,以及 DBS 在不同类型肌张力障碍中的疗效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验